Ads
related to: MRNA Stocknerdwallet.com has been visited by 100K+ users in the past month
Search results
CureVac (NASDAQ:CVAC) Shares Gap Up to $2.44
ETF DAILY NEWS· 3 days agoCureVac (NASDAQ:CVAC – Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $2.44, but opened at $2.51. CureVac shares last traded ...
Earnings call: CureVac details strategic initiatives and clinical progress By Investing.com
Investing.com· 2 days agoCEO Alexander Zehnder emphasized the company's focus on streamlining operations, including the...
Applied DNA Announces 1-For-20 Reverse Stock Split
Morningstar· 4 days ago(NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-20 stock split of its common stock ...
10 Best Performing Biotech ETFs in 2024
Insider Monkey via Yahoo Finance· 4 days agoIn this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just...
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Zacks via Yahoo Finance· 4 days agoAnd, most ETFs are very transparent products that disclose...in the Healthcare sector - about 100%...
Is First Trust NASDAQ-100 Equal Weighted ETF (QQEW) a Strong ETF Right Now?
Zacks via Yahoo Finance· 4 days agoAnd, most ETFs are very transparent products that disclose...Discretionary and Healthcare round out...
Altamira reports publication of positive results from NASAR clinical trial with Bentrio
Seeking Alpha· 2 days agoAltamira Therapeutics (CYTO) shares surge as positive results from the NASAR trial of their Bentrio nasal spray for allergic rhinitis are published.
Pfizer (NYSE:PFE) Trading 0.9% Higher
ETF DAILY NEWS· 6 days agoShares of Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.9% during mid-day trading on Friday . The stock traded as high as $25.66 and last traded at $25.62. 10,092,678 ...
REITs Q1 Earnings Begin On Solid Note
Benzinga via Yahoo Finance· 3 days agoGiven the recent talk about higher interest rates being a headwind for real estate investment trusts (REITs), investors might anticipate that...
Cartesian Therapeutics (NASDAQ:RNAC) Price Target Raised to $54.00 at HC Wainwright
ETF DAILY NEWS· 4 days agoCartesian Therapeutics (NASDAQ:RNAC – Get Free Report) had its price target raised by research analysts at HC Wainwright from $2.00 to $54.00 in a research note issued to investors on Tuesday ...
